ITK inhibitors (Pfizer)

N/A

Report date: 2025/06/11 20:01:15

NME

Base Information

Drug NameITK inhibitors (Pfizer)

Drug Alias Nameinterleukin-2 (IL-2)-inducible T-cell kinase inhibitors (Pfizer)PF-3198926PF-2721335

ClassificationSmall molecules

Mechanisms of ActionTyrosine-protein kinase ITK/TSK inhibitors

TargetsTyrosine-protein kinase ITK/TSK

Therapy Area/IndicationsInflammation

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesPfizer Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesPfizer Inc

Active IndicationsN/A

Inactive IndicationsInflammation

ATC CodeN/A